Could Cannabis Address the Placebo Challenge in Psychedelic Trials?

February 21, 2024

Rick Doblin to Join Numinus as Unpaid Strategic Adviser

February 15, 2024

Unlimited Sciences Launches Psychedelic Info Line for Evidence-Based Exploration

February 8, 2024

What Is Ibogaine?

January 16, 2024

MindBio Therapeutics Reports Progress on LSD Trial for Depression

December 21, 2023

Compass Pathways Psilocybin Trial Shows 80% Remission Rate in Bipolar II Disorder

December 7, 2023